Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOX1416 placebo-controlled randomized study in chronic diabetic foot ulcers
MOH_2023-04-13_012522Phase 2Completed
- Sponsor
- NOxy Health Products
- Start
- Mar 2023
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in diabetic foot ulcer (DFU) comparing NOX1416 + standard of care with Placebo + standard of care (2 arms). Started Mar 2023; status: completed.
02
Drugs
NOX-1416 + SOC
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on MOH_2023-04-13_012522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-04-13_012522.